These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 2058629)
1. Relationship of HBsAg subtypes with HBeAg/anti-HBe status and chronic liver disease. Part I: Analysis of 1744 HBsAg carriers. Shiina S; Fujino H; Uta Y; Tagawa K; Unuma T; Yoneyama M; Ohmori T; Suzuki S; Kurita M; Ohashi Y Am J Gastroenterol; 1991 Jul; 86(7):866-71. PubMed ID: 2058629 [TBL] [Abstract][Full Text] [Related]
2. Relationship of HBsAg subtypes with HBeAg/anti-HBe status and chronic liver disease. Part II: Evaluation of epidemiological factors and suspected risk factors of liver dysfunction. Shiina S; Fujino H; Kawabe T; Tagawa K; Unuma T; Yoneyama M; Ohmori T; Suzuki S; Kurita M; Ohashi Y Am J Gastroenterol; 1991 Jul; 86(7):872-5. PubMed ID: 2058630 [TBL] [Abstract][Full Text] [Related]
3. [Clinical significance of HBeAg and anti-HBe in HBsAg positive liver diseases]. Takahashi A; Sekiya C; Yazaki Y; Tominaga Y; Oohara K; Ono M; Sato H; Hasebe C; Namiki M Hokkaido Igaku Zasshi; 1983 Jan; 58(1):30-42. PubMed ID: 6840666 [TBL] [Abstract][Full Text] [Related]
4. [Can HBsAg levels guide to differentiate inactive HBsAg carriers from HBeAg negative chronic B hepatitis?]. Sayan M; Mutlu B; Erdoğan S; Meriç M; Willke A Mikrobiyol Bul; 2007 Jan; 41(1):87-93. PubMed ID: 17427556 [TBL] [Abstract][Full Text] [Related]
5. [Radioimmunological determination of HBeAg/anti-HBe in HBsAg-positive liver diseases and in "healthy" HBsAg carriers]. Arnold W; Hess G; Dormeyer HH; Gahl G; Hoffmann HG; Knolle J; Schönborn H Z Gastroenterol; 1979 Oct; 17(10):704-12. PubMed ID: 118595 [TBL] [Abstract][Full Text] [Related]
6. HBsAg subtypes among HBsAg carriers in Okinawa, Japan. Evidence of an important relationship in seroconversion from HBeAg to anti-HBe. Noguchi A; Hayashi J; Nakashima K; Hirata M; Ikematsu H; Kashiwagi S J Infect; 1994 Mar; 28(2):141-50. PubMed ID: 8034993 [TBL] [Abstract][Full Text] [Related]
7. Chronic carriers of hepatitis B virus in Bangladesh: a comparative analysis of HBV-DNA, HBeAg/anti-HBe, and liver function tests. Hasan KN; Rumi MA; Hasanat MA; Azam MG; Ahmed S; Salam MA; Islam LN; Hassan MS Southeast Asian J Trop Med Public Health; 2002 Mar; 33(1):110-7. PubMed ID: 12118438 [TBL] [Abstract][Full Text] [Related]
8. [e/Anti-e system in liver disease]. Resta ML; Freni MA; Berlinghieri G; Ajello A; Crinò M; Ferraù O Boll Soc Ital Biol Sper; 1980 Oct; 56(20):2123-8. PubMed ID: 7459125 [TBL] [Abstract][Full Text] [Related]
9. Evolution of HBeAg/anti-HBe status and its relationship to clinical and histological outcome in chronic HBV carriers in childhood. Sodeyama T; Kiyosawa K; Akahane Y; Tanaka E; Wada S; Oike Y; Nakamura M; Yoda H; Imai Y; Gibo Y Am J Gastroenterol; 1986 Apr; 81(4):239-45. PubMed ID: 3962948 [TBL] [Abstract][Full Text] [Related]
10. An evaluation of transient elastography in the discrimination of HBeAg-negative disease from inactive hepatitis B carriers. Maimone S; Calvaruso V; Pleguezuelo M; Squadrito G; Amaddeo G; Jacobs M; Khanna P; Raimondo G; Dusheiko G J Viral Hepat; 2009 Nov; 16(11):769-74. PubMed ID: 19709363 [TBL] [Abstract][Full Text] [Related]
11. Spontaneous loss of HBeAg and development of anti-HBe during long-term follow-up of blood donors found to be HBsAg-positive. Brown SD; Barbara AJ; Lambert T; Wilson DV Br J Biomed Sci; 1995 Jun; 52(2):106-9. PubMed ID: 8520247 [TBL] [Abstract][Full Text] [Related]
12. Long-term follow-up of hepatitis B virus carriers with normal transaminases levels. Koçak N; Ozen H; Yüce A; Gürakan F Turk J Pediatr; 1998; 40(3):365-72. PubMed ID: 9763900 [TBL] [Abstract][Full Text] [Related]
13. [Follow-up of chronic hepatitis B carriers. Serological course and risk of reactivation]. Bujanda L; García Bengoechea M; Cilla G; Gil I; yArenas JI Rev Esp Enferm Dig; 1996 May; 88(5):335-9. PubMed ID: 8764540 [TBL] [Abstract][Full Text] [Related]
14. Hepatitis Be antigen and antibody in chronic liver diseases and hepatocellular carcinoma. Chen DS; Sung JL; Lai MY Hepatogastroenterology; 1981 Dec; 28(6):288-91. PubMed ID: 6284625 [TBL] [Abstract][Full Text] [Related]
15. Low frequency of precore mutants in anti-hepatitis B e antigen positive subjects with chronic hepatitis B virus infection in Chennai, Southern India. Shanmugam S; Velu V; Nandakumar S; Madhavan V; Shanmugasundaram U; Shankar EM; Murugavel KG; Balakrishnan P; Kumarasamy N; Solomon S; Thyagarajan SP J Microbiol Biotechnol; 2008 Oct; 18(10):1722-8. PubMed ID: 18955826 [TBL] [Abstract][Full Text] [Related]
16. Prevalence of precore mutants in anti-HBe-positive hepatitis B virus carriers in Germany. Knöll A; Rohrhofer A; Kochanowski B; Wurm EM; Jilg W J Med Virol; 1999 Sep; 59(1):14-8. PubMed ID: 10440802 [TBL] [Abstract][Full Text] [Related]
17. Effects of alcohol on the liver in HBsAg carriers. Itoh S; Shimoji K Am J Gastroenterol; 1986 Sep; 81(9):779-82. PubMed ID: 3752040 [TBL] [Abstract][Full Text] [Related]
18. Effects of indomethacin on viral replication markers in asymptomatic carriers of hepatitis B: a randomized, placebo-controlled trial. Bahrami H; Daryani NE; Haghpanah B; Moayyeri A; Moghadam KF; Mirmomen S; Kamangar F Am J Gastroenterol; 2005 Apr; 100(4):856-61. PubMed ID: 15784032 [TBL] [Abstract][Full Text] [Related]
19. Natural history of chronic HBV infection: a cohort study with up to 12 years follow-up in North Greece (part of the Interreg I-II/EC-project). Zacharakis GH; Koskinas J; Kotsiou S; Papoutselis M; Tzara F; Vafeiadis N; Archimandritis AJ; Papoutselis K J Med Virol; 2005 Oct; 77(2):173-9. PubMed ID: 16121378 [TBL] [Abstract][Full Text] [Related]
20. Prevalence of hepatitis B surface antigen, hepatitis B e antigen and antibody, and antigen subtypes in atomic bomb survivors. Neriishi K; Akiba S; Amano T; Ogino T; Kodama K Radiat Res; 1995 Nov; 144(2):215-21. PubMed ID: 7480648 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]